Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 146

1.

Paroxetine use during pregnancy: is it safe?

Thormahlen GM.

Ann Pharmacother. 2006 Oct;40(10):1834-7. Epub 2006 Aug 22. Review.

PMID:
16926304
[PubMed - indexed for MEDLINE]
2.

Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors.

Bar-Oz B, Einarson T, Einarson A, Boskovic R, O'Brien L, Malm H, Bérard A, Koren G.

Clin Ther. 2007 May;29(5):918-26. Review.

PMID:
17697910
[PubMed - indexed for MEDLINE]
3.

Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.

Oberlander TF, Misri S, Fitzgerald CE, Kostaras X, Rurak D, Riggs W.

J Clin Psychiatry. 2004 Feb;65(2):230-7.

PMID:
15003078
[PubMed - indexed for MEDLINE]
4.

SSRI antidepressants and birth defects.

[No authors listed]

Prescrire Int. 2006 Dec;15(86):222-3.

PMID:
17167929
[PubMed - indexed for MEDLINE]
5.

First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage.

Bérard A, Ramos E, Rey E, Blais L, St-André M, Oraichi D.

Birth Defects Res B Dev Reprod Toxicol. 2007 Feb;80(1):18-27.

PMID:
17187388
[PubMed - indexed for MEDLINE]
6.

Risks associated with in utero and lactation exposure to selective serotonin reuptake inhibitors (SSRIs).

Ellfolk M, Malm H.

Reprod Toxicol. 2010 Sep;30(2):249-60. doi: 10.1016/j.reprotox.2010.04.015. Epub 2010 May 4. Review.

PMID:
20447455
[PubMed - indexed for MEDLINE]
7.

[Neonatal withdrawal syndrome to selective serotonin reuptake inhibitors: case report and literature review].

Agut-Quijano T, Martínez-Nadal S, Elizari-Saco MJ, Sala-Castellví P, Vila-Cerén C, Raspall-Torrent F.

Rev Neurol. 2006 Jun 1-15;42(11):660-2. Spanish.

PMID:
16736401
[PubMed - indexed for MEDLINE]
Free Article
8.

Neonatal symptoms following maternal paroxetine treatment: serotonin toxicity or paroxetine discontinuation syndrome?

Haddad PM, Pal BR, Clarke P, Wieck A, Sridhiran S.

J Psychopharmacol. 2005 Sep;19(5):554-7.

PMID:
16166193
[PubMed - indexed for MEDLINE]
9.

Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands.

Bakker MK, Kölling P, van den Berg PB, de Walle HE, de Jong van den Berg LT.

Br J Clin Pharmacol. 2008 Apr;65(4):600-6. Epub 2007 Oct 22.

PMID:
17953715
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy.

Davis RL, Rubanowice D, McPhillips H, Raebel MA, Andrade SE, Smith D, Yood MU, Platt R; HMO Research Network Center for Education, Research in Therapeutics.

Pharmacoepidemiol Drug Saf. 2007 Oct;16(10):1086-94. Review.

PMID:
17729378
[PubMed - indexed for MEDLINE]
11.

Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications.

Moses-Kolko EL, Bogen D, Perel J, Bregar A, Uhl K, Levin B, Wisner KL.

JAMA. 2005 May 18;293(19):2372-83. Review.

PMID:
15900008
[PubMed - indexed for MEDLINE]
12.

First-trimester use of paroxetine and congenital heart defects: a population-based case-control study.

Bakker MK, Kerstjens-Frederikse WS, Buys CH, de Walle HE, de Jong-van den Berg LT.

Birth Defects Res A Clin Mol Teratol. 2010 Feb;88(2):94-100. doi: 10.1002/bdra.20641.

PMID:
19937603
[PubMed - indexed for MEDLINE]
13.

Treatment with selective serotonin reuptake inhibitors in the third trimester of pregnancy: effects on the infant.

Nordeng H, Spigset O.

Drug Saf. 2005;28(7):565-81. Review.

PMID:
15963005
[PubMed - indexed for MEDLINE]
14.

Perinatal outcome following third trimester exposure to paroxetine.

Costei AM, Kozer E, Ho T, Ito S, Koren G.

Arch Pediatr Adolesc Med. 2002 Nov;156(11):1129-32.

PMID:
12413342
[PubMed - indexed for MEDLINE]
15.

Serotonin reuptake inhibitors in pregnancy and the risk of major malformations: a systematic review.

Bellantuono C, Migliarese G, Gentile S.

Hum Psychopharmacol. 2007 Apr;22(3):121-8. Review. Erratum in: Hum Psychopharmacol. 2007 Aug;22(6):413.

PMID:
17397101
[PubMed - indexed for MEDLINE]
16.

Clinical management of perinatal depression: focus on paroxetine.

Newport DJ, Stowe ZN.

Psychopharmacol Bull. 2003 Spring;37 Suppl 1:148-66. Review.

PMID:
14566197
[PubMed - indexed for MEDLINE]
17.

Paroxetine and neonatal withdrawal syndrome.

Pogliani L, Schneider L, Dilillo D, Penagini F, Zuccotti GV.

BMJ Case Rep. 2010 Apr 29;2010. pii: bcr1220092528. doi: 10.1136/bcr.12.2009.2528.

PMID:
22736561
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Paroxetine in the first trimester and the prevalence of congenital malformations.

Cole JA, Ephross SA, Cosmatos IS, Walker AM.

Pharmacoepidemiol Drug Saf. 2007 Oct;16(10):1075-85.

PMID:
17729379
[PubMed - indexed for MEDLINE]
19.

Treating functional impairment of autism with selective serotonin-reuptake inhibitors.

Moore ML, Eichner SF, Jones JR.

Ann Pharmacother. 2004 Sep;38(9):1515-9. Epub 2004 Aug 3. Review.

PMID:
15292500
[PubMed - indexed for MEDLINE]
20.

[Neonatal convulsions and subarachnoid hemorrhage after in utero exposure to paroxetine].

Salvia-Roigés MD, Garcia L, Goncé-Mellgren A, Esqué-Ruiz MT, Figueras-Aloy J, Carbonell-Estrany X.

Rev Neurol. 2003 Apr 16-30;36(8):724-6. Spanish.

PMID:
12717649
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk